בפברואר 2009 התקיים כינוס היסוד של הארגון באוניברסיטת ת"א. בכינוס השתתפו קרוב ל-600 מדענים, נשמעו כ-20 הרצאות והוצגו למעלה מ-120 פוסטרים. הכינוס זכה לחסותה של האגודה האירופאית לחקר הסרטן ונשיאת האגודה, פרופ' אנה-ליזה בורסן-דייל מנורבגיה, נשאה את ההרצאה המרכזית בכינוס.


 

כנס היסוד של החברה הישראלית לחקר הסרטן
17 בפברואר 2009
אוניברסיטת תל אביב


Inaugural meeting of the Israeli Society for Cancer
Research
February 17th, 2009
Tel-Aviv University


 

 

Scientific Program

08:30 Greetings – Chairperson: Isaac P. Witz, Tel Aviv
Prof. Ehud Gazit, Vice President for Research & Development, Tel Aviv University
Prof. Benjamin Sredni, Chief Scientist, Ministry of Health
Ms. Miri Ziv, Director General, The Israel Cancer Association


Session 1.- Molecular Genetics – Chairperson: Tamar Peretz, Jerusalem
09:00 – Gad Rennert- Haifa, Molecular and environmental epidemiology of colorectal cancer in Israel
09:20 – Efrat Levi-Lahad – Jerusalem, Cancer risks in BRCA1 and BRCA2 carriers
09:40 – Moshe Oren – Rehovot, The many faces of p53 in cancer
10:00 – Varda Rotter – Rehovot, Identification and Characterization of p53-associated “Gene Signatures”
involved in Cellular Transformation
10:20 – Doron Ginsberg - Ramat Gan, Novel functions of the transcription factor E2F
10:40 – Coffee & Poster Viewing


Key-note Lecture – Chairperson: Isaac P. Witz, Tel Aviv
11:00 –Anne-Lise Børresen-Dale, President EACR , Oslo,
Molecular profiling of breast cancer; Relevance for early diagnosis and treatment


Session 2.- Functional Genetics - Chairperson: Yinon Ben Neriah, Jerusalem
11:40 – Gideon Rechavi – Tel Aviv, Aberrant RNA editing in cancer
12:00 – Israel Vlodavsky – Haifa, Heparanase: one molecule with multiple functions in inflammation and
cancer progression
12:20 – Eli Keshet – Jerusalem, VEGF-driven angiogenesis
12:40 – Ilan Tsarfati – Tel Aviv, The role of Met in breast cancer: from cell motility to metastasis
13:00 – Lunch & Poster Viewing


Session 3.- Cellular Biology of Cancer Progression –
Chairperson: Yona Keisari, Tel Aviv
14:00 – Dov Zipori - Rehovot - Tumor-initiating cells are a biological entity distinct from stem cells:
lessons from multiple myeloma
14:20 – Michal Neeman – Rehovot, Imaging the contribution of fibroblasts to tumor angiogenesis
14:40 – Ron Apte - Beer Sheva, Regulation of cancer-mediated inflammation by IL-1Rb signaling
15:00 – Eitan Galun – Jerusalem, Inflammation and regeneration in hepatocarcinogenesis
15:20 – Eli Pikarsky – Jerusalem, Early phases of hepatocellular carcinoma – lessons from mouse
models
15:40 – Coffee & Poster Viewing


Session 4.- Novel approaches to Cancer Therapy –
Chairperson: Uri Nir, Ramat Gan
16:10 – Yosef Yarden – Rehovot, Oncogenic signal transduction networks and their implications to
cancer therapy
16:30 – Yoel Kloog – Tel Aviv, Design of the Ras inhibitor Salirasib: From a new concept to an oral
feasibility study in pancreatic cancer
16:50 – Varda Shoshan-Barmatz – Beer Sheva, The mitochondrial protein VDAC as a new target for
cancer therapy
17:10 – Shimon Slavin - Tel Aviv, Stem cell transplantation and cell therapy for the treatment of
hematological malignancies and metastatic solid tumors


17:30 – Poster Prizes and Concluding Remarks –
Chairperson: Eliezer Flescher, Tel Aviv


18:00 - Business Meeting – Chairperson: Eliezer Flescher, Tel Aviv

 

 

 

 


הארגון הישראלי לחקר הסרטן

טורנט - הקמת אתרים